SCHEMBL5263018

SCHEMBL5263018

CNC(=NN)c1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
TOP2A P11388 1/20 0.47
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 4/20 0.46
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
NAPRT Q6XQN6 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 3/20 0.41
HTT P42858 2/20 0.41
PAX8 Q06710 1/20 0.40
PLAU P00749 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
HDAC3 O15379 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14646371 0.79 MAPT (0.42) LMNATOP2AKDM4EALDH1A1CES2
SCHEMBL9768928 0.75 KDM4E (0.68) LMNATOP2AKDM4EALDH1A1CES2
SCHEMBL17963025 0.75 KDM4E (0.68) LMNATOP2AKDM4EALDH1A1CES2
SCHEMBL25162057 0.75 KDM4E (0.68) LMNATOP2AKDM4EALDH1A1CES2
SCHEMBL31494657 0.75 KDM4E (0.68) LMNATOP2AKDM4EALDH1A1CES2
SCHEMBL5313208 0.74 BAZ2B (0.46) KDM4ENAPRTRAB9ASMN1; SMN2NPC1
SCHEMBL5313214 0.74 BAZ2B (0.46) KDM4ENAPRTRAB9ASMN1; SMN2NPC1
SCHEMBL12955737 0.74 CES2 (0.52) LMNAKDM4EALDH1A1CES2CES1
SCHEMBL30129831 0.74 CES2 (0.52) LMNAKDM4EALDH1A1CES2CES1
SCHEMBL18019541 0.74 KMT2A (0.44) LMNATOP2AKDM4EALDH1A1NAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781662-A1 INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME Pfizer, Inc. (US) 2007-05-09 EP disclosed
WO-2006018725-A1 INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME PFIZER INC. (US) 2006-02-23 WO disclosed